| # | Filing Date | Period End Date | Type | Report Link | 
|---|---|---|---|---|
| 1 | 07-28-2025 | 06-30-2025 | 10-Q | |
| 2 | 05-12-2025 | 03-31-2025 | 10-Q | |
| 3 | 03-26-2025 | 12-31-2024 | 10-K | 
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating | 
|---|
 
																	Pfizer Inc. today announced that it has filed a lawsuit against Metsera, Inc., its Board of Directors, and Novo Nordisk, S.A. i...
 
																	Pfizer Inc. (NYSE:PFE) today announced the U.S. Federal Trade Commission has granted early termination of the waiting period un...
 
																	https://www.semafor.com/article/10/30/2025/pfizer-mulls-suing-metsera-novo-over-topping-bid
 
																	
 
																	
 
																	Novo Nordisk's $9 billion offer for Metsera challenges Pfizer's existing merger deal, prompting sharp criticism and pot...
 
																	
 
																	- Reuters
 
																	Pfizer Inc. (NYSE:PFE) is aware of the reckless and unprecedented proposal by Novo Nordisk A/S (NYSE:NVO) to acquire Metsera, I...